Fluor selected for expansion of large-scale biologics manufacturing facility in scandinavia

Irving, texas--(business wire)--fluor corporation (nyse: flr) announced today that the company has been selected by a leading biologics company to perform procurement and construction management for a large-scale biologics drug substance manufacturing facility located in scandinavia. fluor will book the multi-hundred-million-dollar reimbursable contract value in the third quarter of 2022. the facility will produce new capacity for advanced biologics that are used in a variety of treatments incl
FLR Ratings Summary
FLR Quant Ranking